Cost of weight-loss drug Mounjaro could rise significantly
Summary
The price of the weight-loss drug Mounjaro is set to increase by up to 170% for private buyers in the UK due to a decision by its manufacturer, Eli Lilly. This increase won't affect the National Health Service (NHS), as it secured a discounted rate. Around 1.5 million people in the UK use weight-loss drugs, with most of them purchasing privately.Key Facts
- Eli Lilly announced a price increase of up to 170% for the weight-loss drug Mounjaro in the UK.
- The cost for a month's supply could rise from £122 to £330 for the highest dose.
- The NHS will not be impacted by this price increase due to a negotiated discount.
- Around 1.5 million people in the UK use weight-loss drugs, with over half using Mounjaro.
- Approximately 90% of people pay for these drugs privately.
- Eli Lilly explained that the UK initially received lower prices compared to other European countries.
- The company aims to align UK prices with global standards due to changes and new clinical evidence.
- The increase does not reflect the prices NHS patients pay, which remain lower due to prior agreements.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.